eMedicine Specialties > Infectious Diseases > Bacterial Infections
Morganella Infections
Updated: Oct 29, 2009
Introduction
Background
Morganella morganii is a gram-negative rod commonly found in the environment and in the intestinal tracts of humans, mammals, and reptiles as normal flora. Despite its wide distribution, it is an uncommon cause of community-acquired infection and is most often encountered in postoperative and other nosocomial settings. M morganii infections respond well to appropriate antibiotic therapy; however, its natural resistance to many beta-lactam antibiotics may lead to delays in proper treatment.
The genus Morganella belongs to the tribe Proteeae of the family Enterobacteriaceae. The Proteeae, which also include the genera Proteus and Providencia, are important opportunistic pathogens capable of causing a wide variety of nosocomial infections. Currently, Morganella contains only a single species, M morganii, with 2 subspecies, morganii and sibonii. M morganii was previously classified under the genus Proteus as Proteus morganii.
In the late 1930s, M morganii was identified as a cause of urinary tract infections. Anecdotal reports of nosocomial infections began to appear in the literature in the 1950s and 1960s. Tucci and Isenberg reported a cluster epidemic of M morganii infections occurring over a 3-month period at a general hospital in 1977.1 Of these infections, 61% were wound infections and 39% were urinary tract infections.
In 1984, McDermott reported 19 episodes of M morganii bacteremia in 18 patients during a 5.5-year period at a Veterans Administration hospital.2 Eleven of the episodes occurred in surgical patients. The most common source of bacteremia was postoperative wound infection, and most infections occurred in patients who had received recent therapy with a beta-lactam antibiotic. Other important epidemiological risk factors in these studies included the presence of diabetes mellitus or other serious underlying diseases and advanced age.
Pathophysiology
M morganii has been associated with urinary tract infections, sepsis, pneumonia, wound infections, musculoskeletal infections, CNS infections, pericarditis, chorioamnionitis, endophthalmitis, empyema, and spontaneous bacterial peritonitis.
Frequency
United States
M morganii is a rare cause of severe invasive disease. It accounts for less than 1% of nosocomial infections. M morganii is usually opportunistic pathogen in hospitalized patients, particularly those on antibiotic therapy.
Clinical
History
- Urinary tract infections: M morganii is commonly recovered from urine cultures in patients with long-term indwelling urinary catheters.
- In a study of 135 consecutive patients with symptomatic, complicated, multidrug-resistant urinary tract infections, nearly 10% were infected with M morganii.
- Like Proteus species, M morganii has properties that enhance its ability to infect the urinary tract; these include motility and the ability to produce urease.
- Urolithiasis is associated with both genera. Members of the tribe Proteeae account for approximately 50% of cases of urolithiasis associated with urinary tract infections in children.
- Perinatal infections: M morganii has been associated with perinatal infection. Four cases of chorioamnionitis and one case of postpartum endometritis have been reported, and each case involved immunocompetent women.3,4
- Three of the women had received parenteral treatment with ampicillin prior to delivery.
- In 2 of the pregnancies, the neonates were not infected.
- A third neonate developed early-onset sepsis and M morganii bacteremia. He was treated successfully with 10 days of cefotaxime and gentamicin. A fourth neonate, born at 24 weeks' gestation, died within the first 38 hours of life. M morganii was recovered from this neonate's blood, pleural fluid, and peritoneal fluid cultures.
- The fifth case occurred in a mother who had repeated exposures to beta-lactam antibiotics in the months prior to delivery for rheumatic fever prophylaxis and pharyngitis and then had intrapartum ampicillin for chorioamnionitis. Her neonate, born at 35 weeks' gestation, was treated empirically with intravenous ampicillin and gentamicin immediately after delivery, but he developed respiratory distress and petechial and purpuric skin lesions on the second day of life. A chest radiograph revealed a lobar infiltrate. Blood culture findings were positive for M morganii that was resistant to ampicillin and susceptible to cefotaxime and gentamicin. He recovered following a 14-day course of cefotaxime and gentamicin. His mother remained febrile after delivery, with evidence of endometritis and subsequent M morganii urinary tract infection. Her isolate was resistant to ampicillin and gentamicin and was treated successfully with imipenem-cilastatin.
- Two cases of early-onset neonatal sepsis in the absence of maternal infection have been reported. Both involved 32-week–premature neonates born to mothers who had received dexamethasone and ampicillin prior to delivery. Both neonates were treated with cefotaxime and amikacin. One neonate's sepsis responded to treatment; the other neonate died from M morganii infection.
- Late-onset neonatal infection has been reported in 2 neonates: (1) a neonate born at term who presented on the 11th day of life with fever, irritability, and M morganii bacteremia and (2) a 15-day-old neonate with M morganii meningitis and brain abscess.5
- Fatal necrotizing fasciitis caused by M morganii and Escherichia coli was reported in a 1-day-old neonate who had been inadvertently dropped into a toilet bowl during a home delivery.6
- Skeletal infections: Four cases of M morganii septic arthritis have been reported in adults. All presented as chronic indolent infections. In contrast to the aggressive and destructive joint disease associated with Proteus mirabilis septic arthritis, the cases of M morganii arthritis were remarkable for their benign clinical presentations and lack of joint damage despite a prolonged course.7,8,9
- Snakebites: M morganii is commonly found in the mouths of snakes. As a result, it is one of the organisms recovered most often from snakebite infections. Jorge (1994) recovered M morganii from 57% of abscesses occurring at the site of Bothrops (ie, the American Lanceheads) bites.10
- Scombroid poisoning: M morganii produces the enzyme histidine decarboxylase, which reacts with histidine, a free amino acid present in the muscle of some species of fin fish, including tunas, mahimahi, sardines, and mackerel. When these fish are improperly stored, spoilage from M morganii may cause the decarboxylation of histidine into histamine. Scombroid poisoning, an anaphylacticlike clinical syndrome, is caused by ingestion of the histamine-containing fish.11,12
- Infections in people with AIDS: Two case reports of M morganii infection in patients with AIDS exist: a 45-year-old man with meningitis13 and a 31-year-old man with pyomyositis.14
- Bacteremia: In a retrospective review of 73 patients with M morganii bacteremia in Taiwan, 70% cases were community acquired and 45% were associated with polymicrobial bacteremia. The most common portals of entry were the urinary tract and hepatobiliary tract. Polymicrobial infection was most commonly associated with hepatobiliary disease. The overall mortality rate was 38%. The most important risk factor for mortality was inappropriate antibiotic therapy.
- CNS infections: CNS infections are rare. Six adult cases have been reported, including 3 cases of meningitis and 3 cases of brain abscess. The most common presentation was fever and altered mental status. Two of the patients with meningitis died. Two patients with brain abscess survived, one with long-term neurological sequelae.15
Physical
- Physical findings are similar to those of other gram-negative infections.
- Ecthyma gangrenosum–like eruptions and hemorrhagic bullae have been associated with M morganii sepsis.
- One 15-year-old girl with recurrent episodes of Henoch-Schönlein purpura was found to have a tuboovarian abscess caused by M morganii. Treatment of the infection resulted in complete remission of the vasculitis.16
Causes
Risk factors for M morganii infection include the following:
- Prior exposure to ampicillin and other beta-lactam antibiotics
- Diabetes mellitus
- Advanced age
- Surgical procedures
- Perinatal exposure
- Abscesses or soft tissue infections following snakebite
More on Morganella Infections |
Overview: Morganella Infections |
| Differential Diagnoses & Workup: Morganella Infections |
| Treatment & Medication: Morganella Infections |
| Follow-up: Morganella Infections |
| References |
| Next Page » |
References
Tucci V, Isenberg HD. Hospital cluster epidemic with Morganella morganii. J Clin Microbiol. Nov 1981;14(5):563-6. [Medline].
McDermott C, Mylotte JM. Morganella morganii: epidemiology of bacteremic disease. Infect Control. Mar 1984;5(3):131-7. [Medline].
Johnson JR, Feingold M. Case of chorioamnionitis in an immunocompetent woman caused by Morganella morganii. J Matern Fetal Med. Jan-Feb 1998;7(1):13-4. [Medline].
Ranu SS, Valencia GB, Piecuch S. Fatal early onset infection in an extremely low birth weight infant due to Morganella morganii. J Perinatol. Oct-Nov 1999;19(7):533-5. [Medline].
Verboon-Maciolek M, Vandertop WP, Peters AC, et al. Neonatal brain abscess caused by Morganella morgagni. Clin Infect Dis. Feb 1995;20(2):471. [Medline].
Krebs VL, Koga KM, Diniz EM. Necrotizing fasciitis in a newborn infant: a case report. Rev Hosp Clin Fac Med Sao Paulo. Mar-Apr 2001;56(2):59-62. [Medline]. [Full Text].
Gautam V, Gupta V, Joshi RM, et al. Morganella morganii-associated arthritis in a diabetic patient. J Clin Microbiol. Jul 2003;41(7):3451. [Medline].
Katz LM, Lewis RJ, Borenstein DG. Successful joint arthroplasty following Proteus morganii (Morganella morganii) septic arthritis: a four-year study. Arthritis Rheum. May 1987;30(5):583-5. [Medline].
Schonwetter RS, Orson FM. Chronic Morganella morganii arthritis in an elderly patient. J Clin Microbiol. Jul 1988;26(7):1414-5. [Medline].
Jorge MT, Ribeiro LA, da Silva ML, et al. Microbiological studies of abscesses complicating Bothrops snakebite in humans: a prospective study. Toxicon. Jun 1994;32(6):743-8. [Medline].
Lopez-Sabater EI, Rodriguez-Jerez JJ, Hernandez-Herrero M, et al. Incidence of histamine-forming bacteria and histamine content in scombroid fish species from retail markets in the Barcelona area. Int J Food Microbiol. Jan 1996;28(3):411-8. [Medline].
Otwell WS. Scombroid Poisoning. US Food and Drug Administration, Sea Grant Extension Fact Sheet. 1995;[Full Text].
Mastroianni A, Coronado O, Chiodo F. Morganella morganii meningitis in a patient with AIDS. J Infect. Nov 1994;29(3):356-7. [Medline].
Arranz-Caso JA, Cuadrado-Gomez LM, Romanik-Cabrera J, et al. Pyomyositis caused by Morganella morganii in a patient with AIDS. Clin Infect Dis. Feb 1996;22(2):372-3. [Medline].
Abdalla J, Saad M, Samnani I, et al. Central nervous system infection caused by Morganella morganii. Am J Med Sci. Jan 2006;331(1):44-7. [Medline].
Pomeranz A, Korzets Z, Eliakim A, et al. Relapsing Henoch-Schonlein purpura associated with a tubo-ovarian abscess due to Morganella morganii. Am J Nephrol. 1997;17(5):471-3. [Medline].
Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother. Mar 2008;52(3):995-1000. [Medline].
Bagel J, Grossman ME. Hemorrhagic bullae associated with Morganella morganii septicemia. J Am Acad Dermatol. Mar 1985;12(3):575-6. [Medline].
Bensman A, Roubach L, Allouch G, et al. Urolithiasis in children. Presenting signs, etiology, bacteriology and localisation. Acta Paediatr Scand. Nov 1983;72(6):879-83. [Medline].
Casanova-Roman M, Sanchez-Porto A, Casanova-Bellido M. Early-onset neonatal sepsis caused by vertical transmission of Morganella morganii. Scand J Infect Dis. 2002;34(7):534-5. [Medline].
Cox CE. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria. Rev Infect Dis. Nov-Dec 1985;7 Suppl 4:S767-71. [Medline].
Cunningham ET Jr, Whitcher JP, Kim RY. Morganella morganii postoperative endophthalmitis. Br J Ophthalmol. Feb 1997;81(2):170-1. [Medline].
Del Pozo J, Garcia-Silva J, Almagro M, et al. Ecthyma gangrenosum-like eruption associated with Morganella morganii infection. Br J Dermatol. Sep 1998;139(3):520-1. [Medline].
Dutta S, Narang A. Early onset Neonatal Sepsis due to Morganella morganii. Indian Pediatr. 11 7 2004;41(11):1155-1157. [Medline]. [Full Text].
Gebhart-Mueller Y, Mueller P, Nixon B. Unusual case of postoperative infection caused by Morganella morganii. J Foot Ankle Surg. Mar-Apr 1998;37(2):145-7. [Medline].
Isobe H, Motomura K, Kotou K, et al. Spontaneous bacterial empyema and peritonitis caused by Morganella morganii. J Clin Gastroenterol. Jan 1994;18(1):87-8. [Medline].
Lee IK, Liu JW. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia. J Microbiol Immunol Infect. Aug 2006;39(4):328-34. [Medline].
Müller HE. Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces. J Clin Microbiol. Feb 1986;23(2):404-5. [Medline].
O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. Oct 2000;13(4):534-46. [Medline].
Piccolomini R, Cellini L, Allocati N, et al. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. Antimicrob Agents Chemother. Oct 1987;31(10):1644-7. [Medline].
Rowen JL, Lopez SM. Morganella morganii early onset sepsis. Pediatr Infect Dis J. Dec 1998;17(12):1176-7. [Medline].
Salen PN, Eppes S. Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med. Jul 1997;4(7):711-4. [Medline].
Samonis G, Anatoliotaki M, Apostolakou H, et al. Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease. Scand J Infect Dis. 2001;33(7):553-5. [Medline].
Stock I, Wiedemann B. Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis. Mar 1998;30(3):153-65. [Medline].
Williams EW, Hawkey PM, Penner JL, et al. Serious nosocomial infection caused by Morganella morganii and Proteus mirabilis in a cardiac surgery unit. J Clin Microbiol. Jul 1983;18(1):5-9. [Medline].
Further Reading
Keywords
Morganella infection, Morganella morganii, M morganii, Morganella morganii morganii, M morganii morganii, Morganella morganii sibonii, M morganii sibonii, urinary tract infections, UTIs, sepsis, pneumonia, wound infections, musculoskeletal infections, CNS infections, pericarditis, chorioamnionitis, endophthalmitis, empyema, spontaneous bacterial peritonitis, Proteus morganii, P morganii, Morganella morganii infection, M morganii infection, Morganella morganii bacteremia, M morganii bacteremia, urolithiasis, scombroid poisoning
Overview: Morganella Infections